Skip to main content

Table 1 Baseline demographic and clinical characteristics

From: The intensive care infection score – a novel marker for the prediction of infection and its severity

 

Group 1

Groups 2 + 3

P

 

(n = 149)

(n = 152)

 

Age (years)

57 (24)

62 (19)

0.01

Gender (male)

100 (67)

105 (69)

0.72

APACHE II score

22 (10)

22 (8)

0.92

APACHE IV score

63 (38)

60 (34)

0.49

SOFA score

7 (7)

8 (6)

0.06

Comorbidity

   

 Neurologic

39 (26)

41 (27)

0.88

 Cardiac

40 (27)

58 (38)

0.04

 Pulmonary

28 (19)

38 (25)

0.25

 Gastrointestinal

39 (26)

55 (36)

0.05

 Renal

15 (10)

24 (16)

0.14

 DM II

22 (15)

33 (22)

0.13

 Cancer

22 (15)

46 (30)

0.002

 Autoimmune

7 (5)

8 (5)

0.97

Reasons for ICU admission

  

<0.001

 Suspected infection

23 (15)

69 (45)

 

 Respiratory failure

24 (16)

33 (22)

 

 Renal failure

0 (0)

1 (1)

 

 Liver failure

5 (3)

3 (2)

 

 Neurology

31 (21)

8 (5)

 

 CPR

9 (6)

5 (3)

 

 Shock

10 (7)

3 (2)

 

 Trauma

13 (9)

5 (3)

 

 Postoperative

34 (23)

25 (17)

 

Treatment on ICU

   

 Antibiotics

140 (94)

152 (100)

0.02

 Norepinephrine

109 (73)

128 (84)

0.03

 Dobutamine

18 (12)

17 (11)

0.80

 TPN

39 (26)

50 (33)

0.20

 Mechanical ventilation

133 (89)

125 (82)

0.06

 Renal replacement therapy

15 (10)

52 (34)

<0.001

Length of ICU stay (days)

9 (17)

11 (17)

0.49

Length of hospital stay (days)

22 (34)

26 (36)

0.13

Mortality day 28

42 (28)

58 (38)

0.09

Mortality day 90

98 (36)

68 (45)

0.13

  1. Numbers (percentage) or median (interquartile range), where appropriate. Abbreviations: APACHE II acute physiology and chronic health evaluation II, CPR cardiopulmonary resuscitation, DM II diabetes mellitus type II, ECMO extracorporeal membrane oxygenation, SOFA sequential organ failure assessment score, TPN total parenteral nutrition